Search results
30 wrz 2021 · The mainstay of treatment for locoregionally advanced head and neck squamous cell carcinoma (HNSCC) is either surgery followed by adjuvant radiation therapy (aRT) or definitive concurrent chemoradiation (CRT) reserving surgery as salvage therapy, referred to as the organ-preservation approach.
8 wrz 2015 · In this context, our article will review some of these advances, with special emphasis on target volume and organ-at-risk delineation, use of molecular imaging for tumor delineation, dose painting for dose escalation, dose adaptation throughout treatment, and potential benefit of proton therapy.
29 kwi 2022 · The Role of Chemotherapy and Immunotherapy in Metastatic Head and Neck Cancer. Among patients with recurrent HNSCC without distant metastases, some have potentially curative options of salvage resection, radiation, or reirradiation.
2 dni temu · Head and neck squamous cell carcinoma (HNSCC) is a complex cancer requiring a multidisciplinary approach. For patients with locally or regionally advanced disease, surgery and/or radiation are the cornerstones of definitive treatment. Medical therapy plays an important adjunct role in this setting, typically consisting of a platinum-based regimen given as induction, concurrent, or adjuvant ...
1 sty 2020 · Definition. The prognosis and multimodal therapeutic options for patients with head and neck cancer vary depending on epidemiologic factors, anatomical location, and stage. There is...
Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
26 kwi 2017 · We propose to explore how we can move away from a one-size-fits-all approach to radiotherapy treatment for patients with head and neck cancer, and to develop evidence with which to guide personalisation and biological adaptation of radiotherapy to improve outcomes and reduce toxicity.
